BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11100004)

  • 1. GUSTO IV: expanding therapeutic options in acute coronary syndromes.
    Lincoff AM
    Am Heart J; 2000 Dec; 140(6 Suppl):S103-14. PubMed ID: 11100004
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycoprotein IIb/IIIa inhibitors: therapeutic applications in acute ST-segment elevation myocardial infarction.
    Campbell KR; Cantor W; Sketch M; Ohman EM
    Am Heart J; 2000 Dec; 140(6 Suppl):S115-24. PubMed ID: 11100005
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute coronary syndromes without ST-elevation -- treatment].
    Weber M; Hamm C
    Dtsch Med Wochenschr; 2003 Feb; 128(6):273-6. PubMed ID: 12571797
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes.
    Campbell P
    N Engl J Med; 2001 Nov; 345(21):1573-4; author reply 1574-5. PubMed ID: 11794228
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention.
    Ronner E; Dykun Y; van den Brand MJ; van der Wieken LR; Simoons ML
    Eur Heart J; 1998 Nov; 19(11):1608-16. PubMed ID: 9857912
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence.
    Singh S; Gopal AK; Bahl VK
    Indian Heart J; 2005; 57(3):201-9. PubMed ID: 16196176
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Fernandez JS; Sadaniantz A
    Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658
    [No Abstract]   [Full Text] [Related]  

  • 9. [Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].
    Auer J; Berent R; Lassnig E; Weber T; Maurer E; Eber B
    Herz; 2003 Aug; 28(5):393-403. PubMed ID: 12928738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute coronary syndromes and diabetes mellitus.
    Trichon BH; Roe MT
    Diab Vasc Dis Res; 2004 May; 1(1):23-32. PubMed ID: 16305052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilitation of thrombolysis in acute myocardial infarction.
    Gambhir DS
    Indian Heart J; 1999; 51(5):486-8. PubMed ID: 10721636
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
    Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E;
    N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.
    Mehta SR;
    J Invasive Cardiol; 2002 Dec; 14 Suppl E():27E-34E; quiz 35E. PubMed ID: 12668860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet, antithrombotic, and lytic therapy for unstable angina, and the appropriate role of revascularization.
    de Feyter PJ; Ruygrok PN
    Curr Opin Cardiol; 1995 Jul; 10(4):389-98. PubMed ID: 7549081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet glycoprotein IIb/IIIa receptor blockade in unstable coronary disease.
    Chesebro JH; Badimon JJ
    N Engl J Med; 1998 May; 338(21):1539-41. PubMed ID: 9593795
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombolytic therapy for acute myocardial infarct].
    Nordt TK; Bode C
    Internist (Berl); 2001 May; 42(5):659-64. PubMed ID: 11400573
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST segment elevation myocardial infarction.
    Cannon CP
    Coron Artery Dis; 1999 Dec; 10(8):561-6. PubMed ID: 10599534
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in antithrombotic therapy of acute myocardial infarction.
    Gensini GF; Comeglio M; Falai M
    Am Heart J; 1999 Aug; 138(2 Pt 2):S171-6. PubMed ID: 10426878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
    Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
    J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet therapy in interventional cardiology: II. Glycoprotein IIb/IIIa inhibitors.
    Jafary FH; Kimmelstiel CD
    J Thromb Thrombolysis; 2000 Feb; 9(2):163-74. PubMed ID: 10613998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.